Stay updated on Pembrolizumab in Advanced Penile Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Penile Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision tag has been updated from v3.5.3 to v3.5.4, indicating a small internal update to the version history. This change does not alter the study information or the content presented to users.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page revision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's backend or formatting. No changes to the study details or data are introduced.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a minor maintenance release with no changes to the study details or user-facing content.SummaryDifference0.1%

- Check70 days agoChange DetectedVersion 3.5.0 was added and version 3.4.3 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded site revision notice: Revision: v3.4.2. Removed the earlier funding-lapse notice (Revision: v3.4.1) from the page.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Penile Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Penile Cancer Clinical Trial page.